TATE vs. GLB, CWK, PFD, BAKK, GNC, DCG, HFG, BD15, ZAM, and PURE
Should you be buying Tate & Lyle stock or one of its competitors? The main competitors of Tate & Lyle include Glanbia (GLB), Cranswick (CWK), Premier Foods (PFD), Bakkavor Group (BAKK), Greencore Group (GNC), Dairy Crest Group (DCG), Hilton Food Group (HFG), Tate & Lyle (BD15), Zambeef Products (ZAM), and PureCircle (PURE). These companies are all part of the "packaged foods" industry.
Tate & Lyle vs. Its Competitors
Tate & Lyle (LON:TATE) and Glanbia (LON:GLB) are both mid-cap consumer defensive companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations.
76.4% of Tate & Lyle shares are owned by institutional investors. Comparatively, 26.8% of Glanbia shares are owned by institutional investors. 2.2% of Tate & Lyle shares are owned by insiders. Comparatively, 30.6% of Glanbia shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
In the previous week, Tate & Lyle had 6 more articles in the media than Glanbia. MarketBeat recorded 6 mentions for Tate & Lyle and 0 mentions for Glanbia. Tate & Lyle's average media sentiment score of 0.25 beat Glanbia's score of 0.00 indicating that Tate & Lyle is being referred to more favorably in the media.
Tate & Lyle pays an annual dividend of GBX 19 per share and has a dividend yield of 3.5%. Glanbia pays an annual dividend of GBX 37 per share and has a dividend yield of 287.9%. Tate & Lyle pays out 39.6% of its earnings in the form of a dividend. Glanbia pays out 7,340.9% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.
Tate & Lyle has a net margin of 11.41% compared to Glanbia's net margin of 7.89%. Tate & Lyle's return on equity of 15.37% beat Glanbia's return on equity.
Glanbia has higher revenue and earnings than Tate & Lyle. Tate & Lyle is trading at a lower price-to-earnings ratio than Glanbia, indicating that it is currently the more affordable of the two stocks.
Tate & Lyle has a beta of 0.5, meaning that its share price is 50% less volatile than the S&P 500. Comparatively, Glanbia has a beta of 0.47, meaning that its share price is 53% less volatile than the S&P 500.
Tate & Lyle currently has a consensus target price of GBX 670, indicating a potential upside of 22.15%. Given Tate & Lyle's stronger consensus rating and higher possible upside, equities analysts clearly believe Tate & Lyle is more favorable than Glanbia.
Summary
Tate & Lyle beats Glanbia on 12 of the 18 factors compared between the two stocks.
Get Tate & Lyle News Delivered to You Automatically
Sign up to receive the latest news and ratings for TATE and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding TATE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Tate & Lyle Competitors List
Related Companies and Tools
This page (LON:TATE) was last updated on 7/6/2025 by MarketBeat.com Staff
